As we enter the second phase of NHS England and NHS Improvement’s response to COVID-19, health and care system partners are being asked to start stepping up non-COVID-19 urgent services, including preventative work in primary care, where it is safe to do so.
While many elements of the high blood pressure and CVD Prevention work programmes have been paused (e.g. workplace blood pressure testing) to enable social distancing and to relieve immediate workload pressures of COVID-19, CVD prevention remains a priority in Cheshire and Merseyside.
The Cheshire and Merseyside CVD Prevention [COVID-19] Subgroup is a cross-sector group that brings together work programmes from the pre-COVID Cheshire and Merseyside Blood Pressure Board and CVD Prevention subgroups, respectively. The group’s key aims during COVID-19 are to:
- Promote health and wellbeing to minimise population CVD risk
- Empower more patients with atrial fibrillation, high blood pressure and high cholesterol to self-manage these CVD risk factors at home
- Support remote CVD risk management in primary care
- Raise public awareness to seek medical review for acute CVD symptoms (such as heart attack or stroke)
Supporting these aims, a new COVID-19 section in the Happy Hearts website will be launched later this month, helping the public, patients and professionals to navigate and access the many resources available to support CVD prevention during COVID-19. Particular focus is given to the ABC of CVD prevention; Atrial fibrillation, high Blood Pressure and high Cholesterol.